Best Practices for Designing Decentralized Clinical Trials Through Robust Quality Management

Pharmaceutical companies are onboarding innovative solutions to decentralize clinical trials in an effort to make them more patient-centric. Innovations in clinical trials can create positive, disruptive changes if they are managed properly. When managing products or services for decentralized trials, it’s important to have a robust quality management system to be able to effectively and efficiently deliver the solution.

Sponsors and contract research organization (CRO) customers need innovative solutions to increase patient recruitment and retention rates. To maximize their positive impact, these solutions need thoughtful and frequent evaluation. This is where global cross-functional product development and performance improvement projects come into play to keep up with the changing landscape of clinical research.

In this free webinar, two vastly experienced vice presidents from MRN will share their experience and expertise on building systems and processes that maximize the positive impact of innovative solutions.

Speakers

Paul Bodfish, Vice President of Corporate Services, Medical Research Network

A biologist by education, Paul Bodfish has spent over 25 years in the clinical research sector in a variety of roles and is an expert in understanding and overcoming the challenges associated with the regulatory and practical elements of successfully running hybrid clinical trials. Paul is one of the original founders of the Medical Research Network and in his current role is responsible for the ongoing development of MRN’s QMS, which continues to evolve as the industry moves into more decentralised trial models. Paul is also MRN’s representative on the IMI Trials@Home consortium, which is a multi-stakeholder team including academia, SMEs, private foundations and EFPIA members, whose remit is to develop and test remote decentralised methods to streamline data collection, participant recruitment and retention.

Message Presenter

Stuart Redding, Chief Operating Officer, Medical Research Network

Stuart Redding has over 25 years in the clinical research sector, having worked for a number of Sponsors & CROs before joining MRN; Stuart’s experience spans many disciplines including data management, clinical operations, project management, business development, proposals/budgets & marketing.  Stuart was one of the MRN founders in 2006 joining the organisation as Head of Project Management; in 2009 Stuart took on the role of Vice President of Global Business Development & Marketing before stepping up as  Chief Operating Officer in 2017.  Stuart brings incredible insight to the running of decentralized clinical trials, having experienced the many challenges of running clinical trials in traditional models; with overall responsibility for delivering all of MRN’s trial portfolio, Stuart is always focused on maximising performance, improving processes & promoting high quality decentralised approaches.

Message Presenter